Published in:
01-03-2021 | Ultrasound | Brief Communication
CIDP, CMT1B, or CMT1B plus CIDP?
Authors:
Davide Cardellini, Giampietro Zanette, Federica Taioli, Laura Bertolasi, Sergio Ferrari, Tiziana Cavallaro, Gian Maria Fabrizi
Published in:
Neurological Sciences
|
Issue 3/2021
Login to get access
Abstract
Charcot-Marie-Tooth disease type 1 (CMT1) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) have distinct clinical and neurophysiological features that result from dysmyelination in CMT1 and macrophage-mediated segmental demyelination in CIDP. CMT1 may occur in genetically isolated cases with atypical presentations that converge phenotypically with CIDP; in rare cases, however, CMT1 may be complicated by superimposed CIDP. We report the case of a patient harboring a de novo heterozygous null mutation of the myelin protein zero (MPZ) gene and affected by subclinical CMT1B who became symptomatic due to superimposed CIDP. Peripheral nerve high-resolution ultrasound (HRUS) aided in establishing the coexistence of CMT1B and CIDP; the diagnosis was further supported by favorable clinical, neurophysiological, and ultrasound responses to immunoglobulin therapy.